News flash: Old mother hubbard reports the cupboard is barehellip;time for the FDA to let droperidol out of the (Black) box

Brett Faine*, Christopher Hogrefe

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

A quick way for a clinical pharmacist to eliminate himself or herself from "employee of the month" consideration is to mention the term medication shortage. Even with training geared toward maximizing resources, the cumulative disappearance of a plethora of medications for the treatment of nausea, vomiting, and/or primary headaches is almost too much for emergency medicine physicians to manage. With prochlorperazine, metoclopramide, promethazine, and ondansetron in increasingly short supply, it is time for the Food and Drug Administration to revisit droperidol's black box warning driven by QTc interval prolongation, given its questionable validity, and restore droperidol's place in the armamentarium of emergency medicine physicians.

Original languageEnglish (US)
Pages (from-to)1259-1261
Number of pages3
JournalAnnals of Pharmacotherapy
Volume46
Issue number9
DOIs
StatePublished - Sep 1 2012

Keywords

  • Black box warning
  • Droperidol
  • Emergency medicine
  • Medication shortage

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'News flash: Old mother hubbard reports the cupboard is barehellip;time for the FDA to let droperidol out of the (Black) box'. Together they form a unique fingerprint.

Cite this